Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences

This publication has 106 references indexed in Scilit:

• Antifungal Drug Resistance in Aspergillus
  Journal of Infection, 2000
• Cross-Resistance of Clinical Isolates ofCandida albicansandCandida glabratato Over-the-Counter Azoles Used in the Treatment of Vaginitis
  Microbial Drug Resistance, 2000
• Practice Guidelines for the Treatment of Candidiasis
  Clinical Infectious Diseases, 2000
• Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic Fluconazole
  The Journal of Infectious Diseases, 2000
• International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents
  Diagnostic Microbiology and Infectious Disease, 1999
• National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program
  Diagnostic Microbiology and Infectious Disease, 1998
• Fluconazol‐resistente Candida‐Arten bei HIV‐Patienten mit rezidivierenden Candida‐Stomatitiden: Kreuzresistenz zu Itraconazol und Ketoconazol
  Mycoses, 1997
• Eight-Year Surveillance of Non-Albicans Candida spp. in an Oncology Department Prior to and After Fluconazole Had Been Introduced into Antifungal Prophylaxis
  Microbial Drug Resistance, 1997
• Ketoconazole and itraconazole susceptibility of Candida albicans isolated from patients infected with HIV
  Journal of Antimicrobial Chemotherapy, 1995
• Reduced azole susceptibility of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation
  Journal of General Microbiology, 1992